Hyperglycaemia due to insulin resistance caused by interferon-γ
✍ Scribed by Shiba, T.; Higashi, N.; Nishimura, Y.
- Book ID
- 101217869
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 30 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0742-3071
No coin nor oath required. For personal study only.
✦ Synopsis
Marked hyperglycaemia (30.9 mmol l -1 ) during interferon-␥ (IFN-␥) therapy for asymptomatic recurrent renal cancer as multiple lung metastases in a 52-year-old man is described. Although the involvement of IFN-␥ has been reported in the development of autoimmune diabetes, in this case, antibodies against pancreatic -cells including anti-islet cell antibody (ICA) and anti-glutamic acid decarboxylase (GAD) antibody were negative. Moreover, serum level of immunoreactive insulin (IRI) (11 U ml -1 at fasting) and urinary excretion of C-peptide (108 g day -1 , reference range: 20-130) suggested insulin resistance, supported by results of insulin tolerance tests. With insulin therapy and cessation of IFN-␥, fasting blood glucose concentration returned to 6.2 mmol l -1 , and insulin therapy was discontinued. The injection of IFN-␥ may cause hyperglycaemia because of insulin resistance, rather than -cell injury.
📜 SIMILAR VOLUMES
The complex processes that determine the outcome of the interaction of tumor and host were explored in the operationally simple and reproducible rat D-I 2 ascites tumor model. Animals exhibit weak spontaneous resistance against this tumor that is not augmented by repeated inoculation, by various rou
Highly metastatic, in vivo-selected cells of RAW I 17-H I0 large-cell lymphoma have been shown to be more resistant than poorly metastatic parental RAW I 17-P cells to the cytolytic and cytostatic activities of activated macrophages in co-culture experiments. Activated macrophages are known to produ